A review of ramelteon in the treatment of sleep disorders.

Neuropsychiatric Disease and Treatment
David N Neubauer

Abstract

Ramelteon is a selective melatonin receptor (MT(1) and MT(2)) agonist that has been approved by the US Food and Drug Administration for the treatment of insomnia characterized by difficulty with sleep onset. It is the only approved sleep-promoting medication that does not have a direct sedating effect, but rather enhances sleep through effects on sleep regulatory mechanisms within the suprachiasmatic nucleus. Ramelteon has been shown to have no abuse liability and therefore is not scheduled by the U.S. Drug Enforcement Agency as a controlled substance. It is available as an 8 mg tablet, which should be taken approximately 30 minutes prior to bedtime. The FDA approval contains no limitation on how long the medication may be prescribed.

References

Oct 21, 2004·Brain Research·Nobuhito YukuhiroMasaomi Miyamoto
Feb 8, 2005·Neuropharmacology·Koki KatoMasaomi Miyamoto
Jun 14, 2006·Behavioral Neuroscience·Charles P FranceLance R McMahon
Oct 4, 2006·Archives of General Psychiatry·Matthew W JohnsonRoland R Griffiths
Feb 13, 2007·Sleep & Breathing = Schlaf & Atmung·Meir KrygerThomas Roth
May 24, 2007·Current Medical Research and Opinion·Thomas RothJeffrey Zhang
Nov 13, 2007·The American Journal of Geriatric Pharmacotherapy·Louis J MiniJeff Zhang

❮ Previous
Next ❯

Citations

Sep 11, 2014·International Journal of Molecular Sciences·Moshe Laudon, Anat Frydman-Marom
May 10, 2011·Expert Opinion on Investigational Drugs·D Alan Lankford
Nov 26, 2014·Expert Opinion on Investigational Drugs·Nava Zisapel
Aug 25, 2012·Expert Opinion on Investigational Drugs·Ludovit PaulisMoshe Laudon
Jan 3, 2016·Progress in Neurobiology·Rodrigo Machado-VieiraCarlos A Zarate
May 12, 2009·Neuroscience Letters·Simon P Fisher, David Sugden
Jun 21, 2015·Journal of Intensive Care Medicine·Yoonsun MoGeorge T Abdallah
Jan 1, 2012·Journal of Central Nervous System Disease·M A Quera Salva, S Hartley
Feb 9, 2010·Expert Review of Neurotherapeutics·Sally A FergusonDrew Dawson
Dec 17, 2019·Biomolecules & Therapeutics·Hye Jin JeeYi-Sook Jung
Aug 29, 2012·Journal of Clinical Psychopharmacology·Avinash De Sousa
May 8, 2020·Journal of Strength and Conditioning Research·Masako HoshikawaMichiko Dohi
Sep 7, 2016·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Lynda S Cook
Apr 14, 2011·Anaesthesia and Intensive Care·J Jarratt
Sep 11, 2014·The Annals of Pharmacotherapy·Jessica D Johnsa, Michael W Neville
Jun 5, 2020·CNS Drugs·Kevin A KaplanLorraine Potocki
Dec 22, 2017·Journal of General and Family Medicine·Keisuke SuzukiKoichi Hirata
Jun 4, 2021·Biological & Pharmaceutical Bulletin·Airi YoshimotoNobuyoshi Matsumoto

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.